Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

14 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/14/3166098/0/en/Lexicon-Pharmaceuticals-Presents-Additional-Pilavapadin-Data-in-Diabetic-Peripheral-Neuropathic-Pain-at-19th-Annual-Pain-Therapeutics-Summit.html

08 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/08/3163249/0/en/Lexicon-Pharmaceuticals-Convenes-Roundtable-to-Address-Public-Policy-Gaps-for-People-with-Chronic-Pain.html

23 Sep 2025
// BIOSPACE
https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3154288/0/en/Lexicon-Pharmaceuticals-Announces-Update-on-Submission-of-Additional-Data-to-U-S-FDA-Supporting-the-Benefit-Risk-Profile-of-Zynquista-in-Type-1-Diabetes.html

18 Sep 2025
// BIOSPACE
https://www.biospace.com/drug-development/lexicon-backs-phase-iii-go-decision-for-non-opioid-pain-med-with-post-hoc-analysis

17 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/17/3151499/0/en/Pilavapadin-Provides-Meaningful-Pain-Reduction-in-Adults-with-Diabetic-Peripheral-Neuropathic-Pain-DPNP-in-Data-Presented-at-the-European-Association-for-the-Study-of-Diabetes-EASD.html
ABOUT THIS PAGE